Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
First ECO - Spécialiste de la Veille Commerciale First ECO - Spécialiste de la Veille Commerciale
it services, Software Development
Capitalistic
Not partnership
Not event

1 Mar 2019


ANTABIO ANTABIO
biotech, deeptech, Biotechnology Research
Capitalistic
Partnership
Not event

10 Jan 2022

17 Oct 2023



Association Aïda Association Aïda
healthtech, Government Administration
Other

12 Nov 2021


LabWorld.it LabWorld.it
Software Development
Other

10 Oct 2023


La Dépêche du Midi La Dépêche du Midi
Other

6 Jan 2022


GIANT Innovation Campus GIANT Innovation Campus
Government Administration
Other

15 Feb 2024


Fondation La main à la pâte Fondation La main à la pâte
edtech, Primary and Secondary Education
Other

13 Apr 2022


European Society for Paediatric Infectious Diseases - ESPID European Society for Paediatric Infectious Diseases - ESPID
healthtech, Hospitals and Health Care
Other

25 May 2021


Toulouse School of Economics Toulouse School of Economics
Higher Education, edtech
Other

7 Jan 2022

17 Oct 2023



INSTITUT MÉRIEUX INSTITUT MÉRIEUX
deeptech, healthtech, Government Administration
Other

12 Oct 2021

8 Oct 2024



Radars
Loading...